EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access

Eosinophilic Fasciitis after Covid Infection: A Case Report and Review of Literature

Sweta Boban, Hiral Patel, Jonathan Cutlan, Boban Mathew, Lisa Francis

Clinical Medicine & Research · 2025

DOI: 10.3121/cmr.2025.1907 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Medicine & Research, 2025. Verfasst von Sweta Boban und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of North Dakota, Grand Forks, ND. Hauptthemen laut MEDLINE: Fasciitis, Eosinophilia, COVID-19. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eosinophilic fasciitis (EF) is a rare fibrosing disorder caused by an autoimmune response to an unknown trigger. Many possible triggers have been suggested including strenuous exercise, drug or chemical exposure, and preceding infection. We present a case of a female patient, age 69 years, who developed EF following SARS-CoV-2 infection. There have been several advances in the diagnosis and management of EF since it was first described 50 years ago. EF is a mimic of scleroderma, but key clinical features can be used to differentiate between the two diagnoses. Laboratory abnormalities include eosinophilia, elevated inflammatory markers, and hypergammaglobulinemia. A full thickness biopsy of the skin including muscle and fascia is recommended to confirm the diagnosis. Imaging modalities such as ultrasound and magnetic resonance imaging have been increasingly used in the diagnosis and follow-up of EF. Corticosteroids remain the first line in treatment of EF. Combination of steroids and methotrexate have shown the best possible outcome. Early diagnosis is important for better treatment response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FasciitisEosinophiliaCOVID-19HumansFemaleAgedSARS-CoV-2MethotrexateMagnetic Resonance ImagingDiagnosis, Differential

Stichwörter der Autor:innen

COVID infectionEosinophilic fasciitis

Substanzen

Methotrexate

Autor:innen und Institutionen

  • University of North Dakota, Grand Forks, ND.
  • Marshfield Clinic Health System, Internal Medicine, Marshfield, WI.
  • Marshfield Clinic Health System, Department of Pathology, Marshfield, WI.
  • Marshfield Clinic Health System, Department of Cardiology, Marshfield, WI.
  • Marshfield Clinic Health System, Department of Rheumatology, Marshfield, WI francis.lisa@marshfieldclinic.org.

Zitieren

APA

Boban, S., Patel, H., Cutlan, J., Mathew, B., & Francis, L. (2025). Eosinophilic Fasciitis after Covid Infection: A Case Report and Review of Literature. Clinical Medicine & Research. https://doi.org/10.3121/cmr.2025.1907

Vancouver

Boban S, Patel H, Cutlan J, Mathew B, Francis L. Eosinophilic Fasciitis after Covid Infection: A Case Report and Review of Literature. Clinical Medicine & Research. 2025. doi:10.3121/cmr.2025.1907

BibTeX
@article{Boban2025,
  author = {Boban, Sweta and Patel, Hiral and Cutlan, Jonathan and Mathew, Boban and Francis, Lisa},
  title = {Eosinophilic Fasciitis after Covid Infection: A Case Report and Review of Literature},
  journal = {Clinical Medicine & Research},
  year = {2025},
  doi = {10.3121/cmr.2025.1907}
}
Kostenlos starten →